See the DrugPatentWatch profile for Trulance
What is Trulance and what is IBS-D?
Trulance (plecanatide) is a prescription medication used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) [1]. IBS-D, or irritable bowel syndrome with diarrhea, is a different condition from IBS-C [2].
How does Trulance work for IBS-C?
Trulance is a guanylate cyclase-C (GC-C) agonist. It works by activating GC-C receptors in the intestinal wall. This activation increases the secretion of chloride and bicarbonate into the intestinal lumen, which leads to increased fluid secretion. This increased fluid softens the stool and stimulates intestinal motility, helping to relieve constipation associated with IBS-C [1].
What is the difference between Trulance and drugs for IBS-D?
Trulance is indicated for IBS-C, which is characterized by constipation. Drugs for IBS-D are designed to manage diarrhea, which is the primary symptom of that condition. For instance, linaclotide is another GC-C agonist that, like Trulance, is approved for both CIC and IBS-C [1]. However, treatments for IBS-D focus on different mechanisms, such as reducing bowel motility or altering gut sensitivity [2].
When might Trulance be prescribed?
A healthcare provider may prescribe Trulance for individuals experiencing the chronic constipation associated with IBS-C. It is taken orally once daily [1].
What are the key differences between Trulance and linaclotide?
Both Trulance (plecanatide) and linaclotide are guanylate cyclase-C (GC-C) agonists approved for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) [1]. While they share a similar mechanism of action, they are distinct molecules with potentially different efficacy and tolerability profiles for individual patients.
Are there any specific patent or exclusivity details for Trulance?
Information regarding the specific patent and exclusivity details for Trulance (plecanatide) can be found on DrugPatentWatch.com [3]. These details are crucial for understanding when generic versions of the drug may become available.
What clinical data supports Trulance's use?
Clinical trials have demonstrated that Trulance is effective in improving abdominal pain and bowel habits in patients with IBS-C. It has been shown to significantly increase the frequency of spontaneous bowel movements and reduce abdominal pain compared to placebo [1].
What are potential side effects of Trulance?
The most common side effect of Trulance is diarrhea. Other potential side effects include abdominal pain, flatulence, and nausea. Patients experiencing severe or persistent diarrhea should contact their healthcare provider [1].
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com